Research of Aldosterone Breakthrough by Aliskire
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000006974
- Lead Sponsor
- Control of organ function, Kanazawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnancy or Breastfeeding 2)Malignant hypertension, secondary hypertension 3)Patients with severe cardiovascular deseases or history(history of acute coronary syndrome, stroke within 6 month) 4)Patients with severe liver damage 5)Hypersensitivity of aliskiren or valsartan 6)Patients who receive Hormone replacement therapy 7)Anyconditions not suitable for the participation in this trial judged by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method